25 XP   0   0   10

Pulike Biological Engineering
Buy, Hold or Sell?

Let's analyse Pulike together

PenkeI guess you are interested in Pulike Biological Engineering. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pulike Biological Engineering. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pulike Biological Engineering

I send you an email if I find something interesting about Pulike Biological Engineering.

Quick analysis of Pulike (30 sec.)










What can you expect buying and holding a share of Pulike? (30 sec.)

How much money do you get?

How much money do you get?
¥0.10
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥7.93
Expected worth in 1 year
¥18.84
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥11.63
Return On Investment
67.6%

For what price can you sell your share?

Current Price per Share
¥17.20
Expected price per share
¥15.83 - ¥20.76
How sure are you?
50%

1. Valuation of Pulike (5 min.)




Live pricePrice per Share (EOD)

¥17.20

Intrinsic Value Per Share

¥-5.22 - ¥0.95

Total Value Per Share

¥2.71 - ¥8.88

2. Growth of Pulike (5 min.)




Is Pulike growing?

Current yearPrevious yearGrowGrow %
How rich?$386.1m$248.4m$137.7m35.7%

How much money is Pulike making?

Current yearPrevious yearGrowGrow %
Making money$24m$33.6m-$9.6m-40.2%
Net Profit Margin14.2%22.2%--

How much money comes from the company's main activities?

3. Financial Health of Pulike (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#146 / 1010

Most Revenue
#80 / 1010

Most Profit
#72 / 1010

Most Efficient
#97 / 1010

What can you expect buying and holding a share of Pulike? (5 min.)

Welcome investor! Pulike's management wants to use your money to grow the business. In return you get a share of Pulike.

What can you expect buying and holding a share of Pulike?

First you should know what it really means to hold a share of Pulike. And how you can make/lose money.

Speculation

The Price per Share of Pulike is ¥17.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pulike.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pulike, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.93. Based on the TTM, the Book Value Change Per Share is ¥2.73 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.35 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.18 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pulike.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.070.4%0.070.4%0.100.6%0.070.4%0.070.4%
Usd Book Value Change Per Share0.382.2%0.382.2%0.050.3%0.090.5%0.090.5%
Usd Dividend Per Share0.020.1%0.020.1%0.060.4%0.040.2%0.030.2%
Usd Total Gains Per Share0.402.3%0.402.3%0.110.6%0.130.8%0.120.7%
Usd Price Per Share3.78-3.78-3.05-2.79-2.82-
Price to Earnings Ratio55.46-55.46-31.33-41.67-46.00-
Price-to-Total Gains Ratio9.41-9.41-27.33-41.75-41.39-
Price to Book Ratio3.45-3.45-4.25-3.68-4.38-
Price-to-Total Gains Ratio9.41-9.41-27.33-41.75-41.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.3736
Number of shares421
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.04
Usd Book Value Change Per Share0.380.09
Usd Total Gains Per Share0.400.13
Gains per Quarter (421 shares)168.9154.41
Gains per Year (421 shares)675.63217.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
14263466660158208
28412671342120316426
312619012018179474644
416825352694239631862
5210316933702997891080
6251380240463599471298
72934436472241811051516
83355070539847812631734
93775703607453814211952
104196337675059815792170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%

Fundamentals of Pulike

About Pulike Biological Engineering

Pulike Biological Engineering, Inc. engages in the research and development, production, and marketing of veterinary biological products and drugs. It offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. The company was founded in 1995 and is headquartered in Luoyang, China.

Fundamental data was last updated by Penke on 2024-04-18 13:01:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pulike Biological Engineering.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pulike earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Pulike to the Biotechnology industry mean.
  • A Net Profit Margin of 14.2% means that ¥0.14 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pulike Biological Engineering:

  • The MRQ is 14.2%. The company is making a huge profit. +2
  • The TTM is 14.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.2%TTM14.2%0.0%
TTM14.2%YOY22.2%-8.0%
TTM14.2%5Y19.7%-5.5%
5Y19.7%10Y24.6%-4.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.2%-207.2%+221.4%
TTM14.2%-216.8%+231.0%
YOY22.2%-282.3%+304.5%
5Y19.7%-436.8%+456.5%
10Y24.6%-597.3%+621.9%
1.1.2. Return on Assets

Shows how efficient Pulike is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pulike to the Biotechnology industry mean.
  • 5.1% Return on Assets means that Pulike generated ¥0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pulike Biological Engineering:

  • The MRQ is 5.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.1%TTM5.1%0.0%
TTM5.1%YOY11.3%-6.1%
TTM5.1%5Y8.0%-2.9%
5Y8.0%10Y10.6%-2.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1%-13.3%+18.4%
TTM5.1%-12.8%+17.9%
YOY11.3%-11.6%+22.9%
5Y8.0%-13.8%+21.8%
10Y10.6%-15.6%+26.2%
1.1.3. Return on Equity

Shows how efficient Pulike is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pulike to the Biotechnology industry mean.
  • 6.2% Return on Equity means Pulike generated ¥0.06 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pulike Biological Engineering:

  • The MRQ is 6.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.2%TTM6.2%0.0%
TTM6.2%YOY13.6%-7.3%
TTM6.2%5Y9.5%-3.3%
5Y9.5%10Y12.6%-3.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2%-16.9%+23.1%
TTM6.2%-16.1%+22.3%
YOY13.6%-14.9%+28.5%
5Y9.5%-19.3%+28.8%
10Y12.6%-20.1%+32.7%

1.2. Operating Efficiency of Pulike Biological Engineering.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pulike is operating .

  • Measures how much profit Pulike makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pulike to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pulike Biological Engineering:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY24.7%-24.7%
TTM-5Y15.2%-15.2%
5Y15.2%10Y15.8%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM--238.5%+238.5%
YOY24.7%-288.4%+313.1%
5Y15.2%-486.2%+501.4%
10Y15.8%-628.4%+644.2%
1.2.2. Operating Ratio

Measures how efficient Pulike is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.19 means that the operating costs are ¥1.19 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Pulike Biological Engineering:

  • The MRQ is 1.192. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.192. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.192TTM1.1920.000
TTM1.192YOY1.098+0.095
TTM1.1925Y1.156+0.037
5Y1.15610Y0.929+0.226
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1923.235-2.043
TTM1.1923.310-2.118
YOY1.0983.838-2.740
5Y1.1565.679-4.523
10Y0.9297.823-6.894

1.3. Liquidity of Pulike Biological Engineering.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pulike is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.03 means the company has ¥3.03 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Pulike Biological Engineering:

  • The MRQ is 3.031. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.031. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.031TTM3.0310.000
TTM3.031YOY2.122+0.909
TTM3.0315Y3.334-0.303
5Y3.33410Y3.406-0.072
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0313.863-0.832
TTM3.0314.169-1.138
YOY2.1225.337-3.215
5Y3.3346.122-2.788
10Y3.4066.434-3.028
1.3.2. Quick Ratio

Measures if Pulike is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pulike to the Biotechnology industry mean.
  • A Quick Ratio of 2.12 means the company can pay off ¥2.12 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pulike Biological Engineering:

  • The MRQ is 2.116. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.116. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.116TTM2.1160.000
TTM2.116YOY1.061+1.055
TTM2.1165Y1.786+0.331
5Y1.78610Y2.097-0.311
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1163.504-1.388
TTM2.1163.991-1.875
YOY1.0615.371-4.310
5Y1.7866.088-4.302
10Y2.0976.395-4.298

1.4. Solvency of Pulike Biological Engineering.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pulike assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pulike to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.17 means that Pulike assets are financed with 17.4% credit (debt) and the remaining percentage (100% - 17.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pulike Biological Engineering:

  • The MRQ is 0.174. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.174. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.174TTM0.1740.000
TTM0.174YOY0.170+0.004
TTM0.1745Y0.155+0.019
5Y0.15510Y0.152+0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1740.339-0.165
TTM0.1740.337-0.163
YOY0.1700.271-0.101
5Y0.1550.368-0.213
10Y0.1520.388-0.236
1.4.2. Debt to Equity Ratio

Measures if Pulike is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pulike to the Biotechnology industry mean.
  • A Debt to Equity ratio of 21.0% means that company has ¥0.21 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pulike Biological Engineering:

  • The MRQ is 0.210. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.210. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.210TTM0.2100.000
TTM0.210YOY0.204+0.006
TTM0.2105Y0.183+0.027
5Y0.18310Y0.180+0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2100.392-0.182
TTM0.2100.403-0.193
YOY0.2040.335-0.131
5Y0.1830.427-0.244
10Y0.1800.461-0.281

2. Market Valuation of Pulike Biological Engineering

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Pulike generates.

  • Above 15 is considered overpriced but always compare Pulike to the Biotechnology industry mean.
  • A PE ratio of 55.46 means the investor is paying ¥55.46 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pulike Biological Engineering:

  • The EOD is 34.863. Based on the earnings, the company is overpriced. -1
  • The MRQ is 55.457. Based on the earnings, the company is expensive. -2
  • The TTM is 55.457. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD34.863MRQ55.457-20.594
MRQ55.457TTM55.4570.000
TTM55.457YOY31.326+24.130
TTM55.4575Y41.671+13.786
5Y41.67110Y46.003-4.333
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD34.863-2.300+37.163
MRQ55.457-2.656+58.113
TTM55.457-2.718+58.175
YOY31.326-4.145+35.471
5Y41.671-6.258+47.929
10Y46.003-6.315+52.318
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pulike Biological Engineering:

  • The EOD is -49.100. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -78.104. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -78.104. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-49.100MRQ-78.104+29.003
MRQ-78.104TTM-78.1040.000
TTM-78.104YOY-72.832-5.271
TTM-78.1045Y21.845-99.949
5Y21.84510Y58.479-36.634
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-49.100-2.974-46.126
MRQ-78.104-3.306-74.798
TTM-78.104-3.508-74.596
YOY-72.832-5.613-67.219
5Y21.845-8.378+30.223
10Y58.479-8.873+67.352
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pulike is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.45 means the investor is paying ¥3.45 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Pulike Biological Engineering:

  • The EOD is 2.169. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.450. Based on the equity, the company is fair priced.
  • The TTM is 3.450. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.169MRQ3.450-1.281
MRQ3.450TTM3.4500.000
TTM3.450YOY4.248-0.797
TTM3.4505Y3.684-0.234
5Y3.68410Y4.380-0.696
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.1691.914+0.255
MRQ3.4502.116+1.334
TTM3.4502.097+1.353
YOY4.2482.881+1.367
5Y3.6843.550+0.134
10Y4.3803.936+0.444
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Pulike Biological Engineering compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.7272.7270%0.354+670%0.679+301%0.666+310%
Book Value Per Share--7.9307.9300%5.203+52%5.500+44%4.389+81%
Current Ratio--3.0313.0310%2.122+43%3.334-9%3.406-11%
Debt To Asset Ratio--0.1740.1740%0.170+2%0.155+12%0.152+14%
Debt To Equity Ratio--0.2100.2100%0.204+3%0.183+15%0.180+17%
Dividend Per Share--0.1800.1800%0.455-60%0.257-30%0.192-6%
Eps--0.4930.4930%0.705-30%0.513-4%0.472+4%
Free Cash Flow Per Share---0.350-0.3500%-0.303-13%-0.008-98%0.133-364%
Free Cash Flow To Equity Per Share---0.350-0.3500%-0.759+117%-0.322-8%0.106-432%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.946--------
Intrinsic Value_10Y_min---5.215--------
Intrinsic Value_1Y_max--0.125--------
Intrinsic Value_1Y_min---0.236--------
Intrinsic Value_3Y_max--0.352--------
Intrinsic Value_3Y_min---0.962--------
Intrinsic Value_5Y_max--0.552--------
Intrinsic Value_5Y_min---1.958--------
Market Cap5952266675.200-62%9655797437.2809655797437.2800%7647970553.600+26%7022423866.848+37%7099182915.312+36%
Net Profit Margin--0.1420.1420%0.222-36%0.197-28%0.246-42%
Operating Margin----0%0.247-100%0.152-100%0.158-100%
Operating Ratio--1.1921.1920%1.098+9%1.156+3%0.929+28%
Pb Ratio2.169-59%3.4503.4500%4.248-19%3.684-6%4.380-21%
Pe Ratio34.863-59%55.45755.4570%31.326+77%41.671+33%46.003+21%
Price Per Share17.200-59%27.36027.3600%22.100+24%20.184+36%20.460+34%
Price To Free Cash Flow Ratio-49.100+37%-78.104-78.1040%-72.832-7%21.845-458%58.479-234%
Price To Total Gains Ratio5.916-59%9.4119.4110%27.334-66%41.752-77%41.391-77%
Quick Ratio--2.1162.1160%1.061+99%1.786+19%2.097+1%
Return On Assets--0.0510.0510%0.113-54%0.080-36%0.106-51%
Return On Equity--0.0620.0620%0.136-54%0.095-35%0.126-50%
Total Gains Per Share--2.9072.9070%0.809+260%0.936+210%0.858+239%
Usd Book Value--386192863.161386192863.1610%248462392.098+55%264146838.026+46%210373099.315+84%
Usd Book Value Change Per Share--0.3760.3760%0.049+670%0.094+301%0.092+310%
Usd Book Value Per Share--1.0941.0940%0.718+52%0.759+44%0.606+81%
Usd Dividend Per Share--0.0250.0250%0.063-60%0.035-30%0.027-6%
Usd Eps--0.0680.0680%0.097-30%0.071-4%0.065+4%
Usd Free Cash Flow---17060693.150-17060693.1500%-14491123.666-15%-451647.173-97%6312909.029-370%
Usd Free Cash Flow Per Share---0.048-0.0480%-0.042-13%-0.001-98%0.018-364%
Usd Free Cash Flow To Equity Per Share---0.048-0.0480%-0.105+117%-0.044-8%0.015-432%
Usd Market Cap821412801.178-62%1332500046.3451332500046.3450%1055419936.397+26%969094493.625+37%979687242.313+36%
Usd Price Per Share2.374-59%3.7763.7760%3.050+24%2.785+36%2.823+34%
Usd Profit--24027676.75024027676.7500%33690962.105-29%24281704.089-1%22450130.516+7%
Usd Revenue--169466273.751169466273.7510%151602398.287+12%124927270.911+36%97486633.337+74%
Usd Total Gains Per Share--0.4010.4010%0.112+260%0.129+210%0.118+239%
 EOD+3 -5MRQTTM+0 -0YOY+17 -185Y+14 -2110Y+17 -18

3.2. Fundamental Score

Let's check the fundamental score of Pulike Biological Engineering based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1534.863
Price to Book Ratio (EOD)Between0-12.169
Net Profit Margin (MRQ)Greater than00.142
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.116
Current Ratio (MRQ)Greater than13.031
Debt to Asset Ratio (MRQ)Less than10.174
Debt to Equity Ratio (MRQ)Less than10.210
Return on Equity (MRQ)Greater than0.150.062
Return on Assets (MRQ)Greater than0.050.051
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Pulike Biological Engineering based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.883
Ma 20Greater thanMa 5017.689
Ma 50Greater thanMa 10017.006
Ma 100Greater thanMa 20018.471
OpenGreater thanClose17.070
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,386,569
Total Liabilities588,070
Total Stockholder Equity2,798,499
 As reported
Total Liabilities 588,070
Total Stockholder Equity+ 2,798,499
Total Assets = 3,386,569

Assets

Total Assets3,386,569
Total Current Assets1,680,313
Long-term Assets1,706,256
Total Current Assets
Cash And Cash Equivalents 281,037
Short-term Investments 691,362
Net Receivables 481,636
Inventory 189,657
Other Current Assets 11,018
Total Current Assets  (as reported)1,680,313
Total Current Assets  (calculated)1,654,710
+/- 25,603
Long-term Assets
Property Plant Equipment 945,318
Goodwill 17,812
Intangible Assets 286,466
Long-term Assets Other 48,402
Long-term Assets  (as reported)1,706,256
Long-term Assets  (calculated)1,297,998
+/- 408,258

Liabilities & Shareholders' Equity

Total Current Liabilities554,302
Long-term Liabilities33,768
Total Stockholder Equity2,798,499
Total Current Liabilities
Short Long Term Debt 7,007
Accounts payable 170,294
Other Current Liabilities 600
Total Current Liabilities  (as reported)554,302
Total Current Liabilities  (calculated)177,901
+/- 376,400
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt214
Long-term Liabilities  (as reported)33,768
Long-term Liabilities  (calculated)214
+/- 33,554
Total Stockholder Equity
Retained Earnings 1,078,465
Total Stockholder Equity (as reported)2,798,499
Total Stockholder Equity (calculated)1,078,465
+/- 1,720,034
Other
Capital Stock352,917
Common Stock Shares Outstanding 352,917
Net Invested Capital 2,805,506
Net Working Capital 1,126,011
Property Plant and Equipment Gross 1,318,500



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
582,131
730,679
837,725
1,503,704
1,736,826
1,805,111
1,903,080
1,905,460
1,996,347
2,168,281
3,386,569
3,386,5692,168,2811,996,3471,905,4601,903,0801,805,1111,736,8261,503,704837,725730,679582,131
   > Total Current Assets 
0
0
0
966,131
1,125,214
1,151,850
1,002,712
911,747
879,460
733,431
1,680,313
1,680,313733,431879,460911,7471,002,7121,151,8501,125,214966,131000
       Cash And Cash Equivalents 
157,515
168,339
213,532
391,178
428,628
263,485
451,364
296,109
253,653
168,832
281,037
281,037168,832253,653296,109451,364263,485428,628391,178213,532168,339157,515
       Short-term Investments 
0
0
0
400,000
515,000
700,200
295,000
315,000
265,100
75,000
691,362
691,36275,000265,100315,000295,000700,200515,000400,000000
       Net Receivables 
63,444
83,527
121,770
112,007
117,847
114,568
149,419
168,113
205,117
291,646
481,636
481,636291,646205,117168,113149,419114,568117,847112,007121,77083,52763,444
       Other Current Assets 
4,594
3,120
3,584
2,597
2,083
2,509
305,362
10,475
12,136
10,154
11,018
11,01810,15412,13610,475305,3622,5092,0832,5973,5843,1204,594
   > Long-term Assets 
0
0
0
0
611,612
653,261
900,367
993,713
1,117,588
1,434,850
1,706,256
1,706,2561,434,8501,117,588993,713900,367653,261611,6120000
       Property Plant Equipment 
181,848
293,091
294,171
290,727
333,518
369,283
367,361
395,368
465,607
651,600
945,318
945,318651,600465,607395,368367,361369,283333,518290,727294,171293,091181,848
       Goodwill 
0
0
0
0
0
0
0
17,812
17,812
17,812
17,812
17,81217,81217,81217,8120000000
       Long Term Investments 
0
0
0
6,682
42,327
58,535
290,174
0
0
0
0
0000290,17458,53542,3276,682000
       Intangible Assets 
123,383
120,624
114,941
231,111
214,756
207,520
219,758
219,647
240,977
276,078
286,466
286,466276,078240,977219,647219,758207,520214,756231,111114,941120,624123,383
       Long-term Assets Other 
0
0
0
0
19,280
15,867
20,159
33,946
45,804
65,321
48,402
48,40265,32145,80433,94620,15915,86719,2800000
> Total Liabilities 
141,663
127,349
154,138
166,490
255,906
236,271
267,510
247,418
318,373
367,829
588,070
588,070367,829318,373247,418267,510236,271255,906166,490154,138127,349141,663
   > Total Current Liabilities 
133,893
118,779
125,567
142,194
224,192
206,553
237,632
214,067
289,517
345,591
554,302
554,302345,591289,517214,067237,632206,553224,192142,194125,567118,779133,893
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
7,007
7,0070000000000
       Accounts payable 
21,254
40,837
30,654
21,392
28,167
17,588
42,783
39,166
45,056
48,948
170,294
170,29448,94845,05639,16642,78317,58828,16721,39230,65440,83721,254
       Other Current Liabilities 
62,639
77,942
94,913
65,123
135,498
119,632
113,902
83,516
86,374
245,336
600
600245,33686,37483,516113,902119,632135,49865,12394,91377,94262,639
   > Long-term Liabilities 
0
0
0
0
31,714
29,718
29,878
33,351
27,651
22,237
33,768
33,76822,23727,65133,35129,87829,71831,7140000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
214
2140000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
1,412
1,254
0
0
001,2541,4120000000
> Total Stockholder Equity
440,468
603,330
683,587
1,337,213
1,480,920
1,568,840
1,635,570
1,658,043
1,677,974
1,800,452
2,798,499
2,798,4991,800,4521,677,9741,658,0431,635,5701,568,8401,480,9201,337,213683,587603,330440,468
   Common Stock
120,000
120,000
120,000
160,000
323,740
323,740
323,740
321,496
321,496
321,496
0
0321,496321,496321,496323,740323,740323,740160,000120,000120,000120,000
   Retained Earnings 
240,397
388,173
510,492
604,234
744,236
793,674
865,009
887,911
1,052,473
1,139,289
1,078,465
1,078,4651,139,2891,052,473887,911865,009793,674744,236604,234510,492388,173240,397
   Capital Surplus 00000000000
   Treasury Stock00000-26,995-45,7400000
   Other Stockholders Equity 00000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,329,329
Cost of Revenue-505,478
Gross Profit823,852823,852
 
Operating Income (+$)
Gross Profit823,852
Operating Expense-1,072,905
Operating Income256,424-249,054
 
Operating Expense (+$)
Research Development102,324
Selling General Administrative405,548
Selling And Marketing Expenses-
Operating Expense1,072,905507,872
 
Net Interest Income (+$)
Interest Income3,140
Interest Expense-886
Other Finance Cost-1,892
Net Interest Income4,146
 
Pretax Income (+$)
Operating Income256,424
Net Interest Income4,146
Other Non-Operating Income Expenses-
Income Before Tax (EBT)242,699256,424
EBIT - interestExpense = -886
225,085
225,972
Interest Expense886
Earnings Before Interest and Taxes (EBIT)-243,585
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax242,699
Tax Provision-17,613
Net Income From Continuing Ops225,085225,085
Net Income225,085
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--4,146
 

Technical Analysis of Pulike
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pulike. The general trend of Pulike is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pulike's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pulike Biological Engineering.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 18.72 < 18.80 < 20.76.

The bearish price targets are: 16.65 > 16.33 > 15.83.

Tweet this
Pulike Biological Engineering Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pulike Biological Engineering. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pulike Biological Engineering Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pulike Biological Engineering. The current macd is 0.11704588.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pulike price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Pulike. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Pulike price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pulike Biological Engineering Daily Moving Average Convergence/Divergence (MACD) ChartPulike Biological Engineering Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pulike Biological Engineering. The current adx is 14.40.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pulike shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Pulike Biological Engineering Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pulike Biological Engineering. The current sar is 18.20.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pulike Biological Engineering Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pulike Biological Engineering. The current rsi is 46.88. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Pulike Biological Engineering Daily Relative Strength Index (RSI) ChartPulike Biological Engineering Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pulike Biological Engineering. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pulike price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pulike Biological Engineering Daily Stochastic Oscillator ChartPulike Biological Engineering Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pulike Biological Engineering. The current cci is -88.31469341.

Pulike Biological Engineering Daily Commodity Channel Index (CCI) ChartPulike Biological Engineering Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pulike Biological Engineering. The current cmo is -13.51553614.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pulike Biological Engineering Daily Chande Momentum Oscillator (CMO) ChartPulike Biological Engineering Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pulike Biological Engineering. The current willr is -71.35416667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Pulike is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Pulike Biological Engineering Daily Williams %R ChartPulike Biological Engineering Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pulike Biological Engineering.

Pulike Biological Engineering Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pulike Biological Engineering. The current atr is 0.65797625.

Pulike Biological Engineering Daily Average True Range (ATR) ChartPulike Biological Engineering Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pulike Biological Engineering. The current obv is -73,386,492.

Pulike Biological Engineering Daily On-Balance Volume (OBV) ChartPulike Biological Engineering Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pulike Biological Engineering. The current mfi is 36.63.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pulike Biological Engineering Daily Money Flow Index (MFI) ChartPulike Biological Engineering Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pulike Biological Engineering.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Pulike Biological Engineering Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pulike Biological Engineering based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.883
Ma 20Greater thanMa 5017.689
Ma 50Greater thanMa 10017.006
Ma 100Greater thanMa 20018.471
OpenGreater thanClose17.070
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pulike with someone you think should read this too:
  • Are you bullish or bearish on Pulike? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pulike? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pulike Biological Engineering

I send you an email if I find something interesting about Pulike Biological Engineering.


Comments

How you think about this?

Leave a comment

Stay informed about Pulike Biological Engineering.

Receive notifications about Pulike Biological Engineering in your mailbox!